Hyperphenylalaninemia due to pterin-4-alpha-carbin

Hyperphenylalaninemia due to pterin-4-alpha-carbinolamine dehydratase deficiency is a rare genetic disorder affecting the metabolic processing of the amino acid phenylalanine. This condition is part of a broader category of diseases known as phenylketonuria (PKU) and related disorders, which lead to elevated levels of phenylalanine in the blood, a condition known as hyperphenylalaninemia. The specific cause of this form of hyperphenylalaninemia is a deficiency in the enzyme pterin-4-alpha-carbinolamine dehydratase (PCD), which plays a crucial role in the metabolism of phenylalanine.

Causes and Genetics

The deficiency is caused by mutations in the PCBD1 gene, which provides instructions for making the enzyme needed for the proper metabolism of phenylalanine. The PCBD1 gene mutations lead to reduced activity or complete lack of the PCD enzyme, resulting in the accumulation of phenylalanine in the body. This condition is inherited in an autosomal recessive pattern, meaning that an individual must receive a mutated gene from both parents to be affected.

Symptoms

Symptoms of hyperphenylalaninemia due to PCD deficiency can vary widely among affected individuals. Some may remain asymptomatic, while others develop neurological symptoms such as intellectual disability, seizures, and behavioral problems. The severity of symptoms often correlates with the levels of phenylalanine in the blood.

Diagnosis

Diagnosis typically involves newborn screening tests that detect elevated levels of phenylalanine in the blood. Confirmatory tests, including genetic testing for mutations in the PCBD1 gene and enzyme activity assays for PCD, can establish a definitive diagnosis.

Treatment

Treatment focuses on managing phenylalanine levels through dietary restrictions. Individuals with this condition may need to follow a low-phenylalanine diet to prevent the accumulation of phenylalanine and mitigate the risk of neurological damage. In some cases, supplementation with tetrahydrobiopterin (BH4), a cofactor for phenylalanine metabolism, may be beneficial.

Prognosis

With early diagnosis and appropriate management, individuals with hyperphenylalaninemia due to PCD deficiency can lead healthy lives. However, untreated or poorly managed cases may result in severe neurological complications.

This metabolic pathology related article is a stub. You can help WikiMD by expanding it.